Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 9Gynecologic 3Breast 3Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 3Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 39Specimen Handling 32Carboplatin 32pembrolizumab 31Bevacizumab 24Magnetic Resonance Spectroscopy 23Gemcitabine 15Biopsy 15liposomal doxorubicin 14olaparib 13Cisplatin 11Nivolumab 9Doxorubicin 9Topotecan 8Taxes 8Cyclophosphamide 8fludarabine 7palbociclib 6Surveys and Questionnaires 6Fulvestrant 6lenvatinib 5abemaciclib 5X-Rays 5Immunoglobulin G 5Docetaxel 5Disulfides 51-dodecylpyridoxal 5trastuzumab deruxtecan 4mirvetuximab soravtansine 4dostarlimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
niraparib × Gynecologic × 30 days × Clear all
NCT04295577 2026-05-13

MONITOR-UK

Royal Marsden NHS Foundation Trust

Completed
388 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04502602 2026-05-11

iNNOVATE

Virginia Commonwealth University

Phase 1 Active not recruiting
18 enrolled
Gynecologic

Ovarian Neoplasms

NCT06915025 2026-05-04

OVATION-3

Imunon

Phase 3 Recruiting
500 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡